Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients-Reference-Cited by-同舟云学术

Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients

Published:2020-03 Issue: Volume:73 Page:51-58
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Aigner Christof^ORCID,Böhmig Georg A.,Eskandary Farsad,Herkner Harald,Prohászka Zoltán,Csuka Dorottya^ORCID,Kain Renate,Gaggl Martina^ORCID,Sunder-Plassmann Raute,Müller-Sacherer Thomas,Oszwald André,Fischer Gottfried,Schmidt Alice,Sunder-Plassmann Gere

Funder

Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary

Publisher

Elsevier BV

Subject

Internal Medicine

Reference37 articles.

1. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype;Noris;Clin J Am Soc Nephrol,2010

2. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome;Le Quintrec;Am J Transplant,2013

3. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background;Bresin;Clin J Am Soc Nephrol,2006

4. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?;Hirt-Minkowski;Nephrol Dial Transplant,2009

5. Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation;Davin;Pediatr Nephrol,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination;Kidney International Reports;2023-08

2. Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes;Kidney Medicine;2023-07

3. Egészségügyi szakmai irányelv – A thrombotikus thrombocytopeniás purpura (TTP) és a haemolytikus uraemiás syndroma (HUS) kezeléséről;Orvosi Hetilap;2022-09-19

4. Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice;Frontiers in Immunology;2021-05-12

5. Interventions for atypical haemolytic uraemic syndrome;Cochrane Database of Systematic Reviews;2021-03-30